# PET/CT Imaging of Angiogenesis in Patients With Neuroendocrine Tumors Using 68Ga-NODAGA-E[c(RGDyK)]2

> **NCT03271281** · PHASE2 · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 113 (actual)

## Conditions studied

- Neuroendocrine Tumors

## Interventions

- **DRUG:** One injection of 68Ga-NODAGA-E[c(RGDyK)]2
- **DEVICE:** PET/CT

## Key facts

- **NCT ID:** NCT03271281
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-04
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2022-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03271281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03271281, "PET/CT Imaging of Angiogenesis in Patients With Neuroendocrine Tumors Using 68Ga-NODAGA-E[c(RGDyK)]2". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03271281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*